Xarelto Lawyers Reviewing Cases Nationwide for Bleeding Injury, Wrongful Death

Austin Kirk

By Austin Kirk
Posted June 17, 2014

UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.

The product liability lawyers at Saiontz & Kirk, P.A. are now providing free consultations and claim evaluations for individuals and families throughout the United States who may be entitled to financial compensation through an Xarelto lawsuit.

Xarelto (rivaroxaban) is part of a new class of anticoagulants that have been introduced in recent years as a superior alternative to warfarin (Coumadin) for prevention of strokes, deep vein thrombosis (DVT) and pulmonary embolism. The drug is promoted as easier to use, since it requires less monitoring during treatment.

However, unlike warfarin, there is no effective reversal agent for Xarelto to allow doctors to control bleeding or hemorrhaging that may occur while using the medication. As a result of inadequate warnings provided about the bleeding risk with Xarelto and the lack of an approved antidote, thousands of severe injuries and deaths have been reported among users of the drug.

The first medication approved in the U.S. from this new class of blood thinners was Pradaxa, which has been the subject of several thousand bleeding injury lawsuits. It was announced last month that the maker of that drug will pay an estimated $650 million to settle Pradaxa lawsuits filed by about 4,000 people nationwide.

It appears that similar compensation may be available for users of Xarelto who have required medical treatment, hospitalization or died as a result of:

  • Gastrointestinal Bleeds
  • Brain Hemorrhages
  • Kidney Bleeding
  • Hemorrhagic Stroke
  • Other Uncontrollable Bleeding Problems

Despite information establishing the link between Xarelto and bleeding problems, Johnson & Johnson and Bayer continued to promote this controversial anticoagulant as safe and effective, withholding information about the risk of uncontrollable bleeding and the lack of an antidote.

If the drug makers had taken steps to recall Xarelto, provide stronger warnings or develop a reversal agent, many users throughout the United States may have avoided serious injury or death.

Free Consultation with Xarelto Injury Lawyers

The Xarelto lawyers at Saiontz & Kirk, P.A. are providing free consultations and claim evaluations for former users and their families of individuals who have suffered a severe bleeding injury on Xarelto.

All cases are handled by our law firm under a contingency fee agreement, which means that we only receive an attorney fee or expense reimbursement if we are successful obtaining a recovery.

Saiontz & Kirk is a nationally known personal injury law firm dedicated to the sole purpose of representing those seriously injured as a result of another person or corporation’s negligence.

Our lawyers only represent people who have been injured. We do not defend insurance companies or large corporations, and we have developed a reputation for helping our clients obtain the financial compensation they deserve.

Through the use of contingency fees, our clients have access to the experience and resources of our testosterone law firm — regardless of their individual financial resources.

If you decide to hire our lawyers to pursue your Xarelto bleeding injury or wrongful death lawsuit, your case will be pursued with the energy and devotion you deserve, and there never any out-of-pocket expenses for our clients.

UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.

No Comments • Add Your Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.